Yuki Nakamura

Hiroshima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy.

The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy.

Journal: Journal of medical virology

Published: April 18, 2018

Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C.

Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C.

Journal: Journal of medical virology

Published: March 20, 2018

Timing and Interval Effects of Repeated Inseminations by Roosters on the Fathering of Chicks.

Timing and Interval Effects of Repeated Inseminations by Roosters on the Fathering of Chicks.

Journal: The journal of poultry science

Published: December 15, 2017

Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus-related cirrhosis.

Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus-related cirrhosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 07, 2017

Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma.

Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 23, 2017

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.

Journal: PloS one

Published: March 25, 2017

Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.

Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.

Journal: Journal of medical virology

Published: February 06, 2017

Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.

Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.

Journal: Journal of gastroenterology

Published: January 11, 2017

Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation.

Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation.

Journal: Clinical journal of gastroenterology

Published: January 10, 2017

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 19, 2016

Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction.

Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction.

Journal: Journal of medical virology

Published: September 05, 2016

Assessment of Outcome of Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma by the Combination of RECIST and Tumor Markers.

Assessment of Outcome of Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma by the Combination of RECIST and Tumor Markers.

Journal: Hiroshima journal of medical sciences

Published: September 01, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026